By Katherine Hamilton
Evolv Technologies shares rose after the company raised its sales outlook for the year and said it had resolved some legal and regulatory issues.
The stock was up 8% to $7.93 on Friday, touching a 52-week high of $8.91. Shares have doubled in value this year.
The maker of AI-powered security technology said Thursday it now expects full-year sales to be $132 million to $135 million, up from prior guidance of $125 million to $130 million.
Revenue in the second quarter jumped 29% to $32.5 million, surpassing analysts' forecast of $30.9 million. Annual recurring revenue rose 27% to $110.5 million.
Evolv posted a loss of $40.5 million, or 25 cents a share, compared with a profit of $3.4 million, or 2 cents a share, the year before. The adjusted loss was 2 cents a share.
Evolv has also resolved several regulatory and legal concerns. Management said during an analyst call Friday that the company is no longer the subject of a Justice Department investigation. Evolv had said in November it received a voluntary document request from the U.S. Attorney's Office of the Southern District of New York.
It also said it settled in principle a former securities class action lawsuit. The company expects its exposure to be around $1 million, which will be primarily covered by insurance.
TD Cowen analysts led by Shaul Eyal reinstated a buy rating for Evolv. "We are encouraged by the diminished regulatory risks that have been put to rest as well as improved fundamental outlook," Eyal said in a note.
Write to Katherine Hamilton at katherine.hamilton@wsj.com
(END) Dow Jones Newswires
August 15, 2025 13:55 ET (17:55 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。